Press & Media

Press plays an important role in changing perceptions about obesity. We appreciate partners who can help Form change the conversation from shame and personal failure to an understanding that obesity is a chronic medical condition that can be treated with an empathetic and science backed approach.

For press and influencer inquiries, please email


FORM Launches FORMfit

September 12, 2023

BOSTON--(BUSINESS WIRE)--Today,FORM, the virtual obesity medicine clinic, officially launched FORMfit™, a new program helping employers expand access to high-quality, clinical obesity care while managing costs. The past year has seen surging consumer demand for and rapid adoption of expensive GLP-1 receptor agonists like Ozempic® and Wegovy®. As a result, many employers have seen their pharma costs skyrocket and, in response, moved to completely restrict access to these highly effective drugs to control costs. FORM developed its proprietary offering, FORMfit, to allow employers to expand access to high-impact obesity care while investing in GLP-1s at a level that aligns with their short and long-term goals and budget constraints.